• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY,

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO EUPHORA RX; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, Back to Search Results
Catalog Number EUP1506X
Device Problems Deflation Problem (1149); Difficult to Open or Remove Packaging Material (2922)
Patient Problems Hematoma (1884); Insufficient Information (4580)
Event Date 03/01/2022
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic conducted a post market clinical follow-up (pmcf) survey to seek out potential new risks and assess performance of the eupora, solarice, nc euphora, nc solarice and sprinter legend poba balloon catheters and everest inflation device & accessories.Survey results from a cardiovascular surgeon in practice 25 years.In the past two months the physician has used euphora, sprinter legend and everest devices.The physician uses approximately 5 everest, 4 euphora and 3 sprinter legend devices in an average month.During a procedure two nc euphora devices (2.00 x 6 mm and 2.00 x 8 mm), one 1.50 x 6 mm euphora device, two everest devices and one piton y-adaptor were used to treat a totally occluded small vessel.One nc euphora was used for angioplasty alone and the other was used for pre-dilation.The euphora device was used for pre-dilation.Nc euphora: it was reported that deflation difficulties occurred in vivo and intervention was required, sheath stylette removal difficulties occurred during device preparation in vitro.It was reported that the device which was used for angioplasty alone performed unsuccessfully.It was stated that the other device performed successfully.It was also reported that a local hematoma occurred.Euphora: it was reported that deflation difficulties occurred in vivo and intervention was required, sheath stylette removal difficulties occurred during device preparation in vitro.It was also reported that a local hematoma occurred.Everest: it was reported that connection difficulties and physical resistance/sticking occurred in vitro during device preparation of one of the devices.It was also stated that the device was not functioning well.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EUPHORA RX
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY,
Manufacturer (Section D)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX  22570
Manufacturer (Section G)
MEDTRONIC MEXICO
av. paseo del cucapah #10510
tijuana,bc 22570
MX   22570
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key14487384
MDR Text Key292488298
Report Number9612164-2022-01980
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K143480
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Health Professional
Reporter Occupation Physician
Type of Report Initial
Report Date 05/24/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberEUP1506X
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/29/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-